ERYGLOB

This brand name is authorized in Nigeria.

Active ingredients

The drug ERYGLOB contains one active pharmaceutical ingredient (API):

1	Erythromycin UNII LXW024X05M - ERYTHROMYCIN STEARATE
	Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.
	Read more about Erythromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7737	Tablet	ERYGLOB 500MG TABLET TAB 500 mg 1 X 10Tablets	142 RNW-PP-324313 ERYGLOB 500MG TABLET ERYTHROMYCIN STEARATE BP 500MG ERYTHROMYCIN STEARATE 500MG B4-7737 Drugs Imported Products 110TABLETS POM 1 4/3/2023 UCHE ST. PHARMACEUTICAL COMPANY LIMITED, NO. 9, EKWULUMIRRI STREET, IYIOWA 8034144316 uchestcoy@gmail.com GLOBELA PHARMA PVT. LTD., 357 358, G.I.D.C., SACHIN, SURAT - 394 230, GUJARAT, INDIA, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA01	Erythromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7737